Cardiovascular toxicities from cancer treatment
15 Nov 2017
Cardiovascular toxicities from cancer treatment
The promise of immunotherapy for elderly patients
Making lifestyle decisions surrounding geriatric cancer surgery
Toxicities in treatments of lung cancers with respect to the elderly
Communicating with geriatric patients
Utility and application of cancer screening in geriatrics
Treating AML in patients over 70
Benefits and drawbacks of dexrazoxane
A formulated geriatric assessment and the role of nurses
Screening tools in geriatric oncology
VESPA: a tool for assessing outcomes in a post operative setting
Improving eligibility for the elderly in clinical trails